Nexalin Technology Price To Book vs. Current Valuation

NXL Stock  USD 4.18  0.09  2.11%   
Based on the key profitability measurements obtained from Nexalin Technology's financial statements, Nexalin Technology may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Nexalin Technology's ability to earn profits and add value for shareholders. At this time, Nexalin Technology's Days Sales Outstanding is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 54.81 this year, although the value of EV To Sales will most likely fall to 20.61. Total Other Income Expense Net is expected to rise to about 1.1 M this year, although the value of Accumulated Other Comprehensive Income is projected to rise to (384.75).
For Nexalin Technology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nexalin Technology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nexalin Technology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nexalin Technology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nexalin Technology over time as well as its relative position and ranking within its peers.
  

Nexalin Technology's Revenue Breakdown by Earning Segment

Check out Correlation Analysis.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.65)
Revenue Per Share
0.02
Quarterly Revenue Growth
(0.24)
Return On Assets
(1.19)
Return On Equity
(2.02)
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Nexalin Technology Current Valuation vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Nexalin Technology's current stock value. Our valuation model uses many indicators to compare Nexalin Technology value to that of its competitors to determine the firm's financial worth.
Nexalin Technology is regarded fifth in price to book category among its peers. It is rated below average in current valuation category among its peers reporting about  4,692,035  of Current Valuation per Price To Book. Comparative valuation analysis is a catch-all technique that is used if you cannot value Nexalin Technology by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Nexalin Current Valuation vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Nexalin Technology

P/B

 = 

MV Per Share

BV Per Share

 = 
11.08 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Nexalin Technology

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
51.98 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Nexalin Current Valuation vs Competition

Nexalin Technology is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 5.27 Billion. Nexalin Technology maintains roughly 51.98 Million in current valuation contributing less than 1% to equities under Health Care industry.

Nexalin Technology Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Nexalin Technology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nexalin Technology will eventually generate negative long term returns. The profitability progress is the general direction of Nexalin Technology's change in net profit over the period of time. It can combine multiple indicators of Nexalin Technology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income(405.00)(384.75)
Operating Income-5.7 M-6 M
Income Before Tax-4.6 M-4.9 M
Total Other Income Expense NetM1.1 M
Net Loss-2 M-2.1 M
Net Loss-4.6 M-4.9 M
Income Tax Expense(4.00)(3.80)
Net Interest Income-33.2 K-34.8 K
Net Loss-4.6 M-4.8 M
Change To Netincome86.2 K81.9 K
Net Loss(0.63)(0.66)
Income Quality 0.83  0.43 
Net Income Per E B T 1.02  0.85 

Nexalin Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Nexalin Technology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nexalin Technology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nexalin Technology's important profitability drivers and their relationship over time.

Use Nexalin Technology in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nexalin Technology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexalin Technology will appreciate offsetting losses from the drop in the long position's value.

Nexalin Technology Pair Trading

Nexalin Technology Pair Trading Analysis

The ability to find closely correlated positions to Nexalin Technology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nexalin Technology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nexalin Technology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nexalin Technology to buy it.
The correlation of Nexalin Technology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nexalin Technology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nexalin Technology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nexalin Technology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Nexalin Technology position

In addition to having Nexalin Technology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Strategy ETFs Thematic Idea Now

Strategy ETFs
Strategy ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Strategy ETFs theme has 1282 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Strategy ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:
Check out Correlation Analysis.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
To fully project Nexalin Technology's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nexalin Technology at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nexalin Technology's income statement, its balance sheet, and the statement of cash flows.
Potential Nexalin Technology investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Nexalin Technology investors may work on each financial statement separately, they are all related. The changes in Nexalin Technology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nexalin Technology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.